International Journal of Rheumatology (Jan 2009)

Long-Term Alendronate Use Not without Consequences?

  • M. P. Somford,
  • G. F. A. E. Geurts,
  • J. W. A. M. den Teuling,
  • B. J. W. Thomassen,
  • W. F. Draijer

DOI
https://doi.org/10.1155/2009/253432
Journal volume & issue
Vol. 2009

Abstract

Read online

A previously unknown side effect of biphosphonate use is emerging. In a specific patient group on long term biphosphonate therapy stress femur fractures seem to occur. The typical presentation consists of prodromal pain in the affected leg and/or a discrete cortical thickening on the lateral side of the femur in conventional radiological examination or the presentation with a spontaneous transverse subtrochanteric femur with typical features. We present three cases of this stress fracture in patients on bisphosphonate therapy. One of these patients suffered a bilateral femur fracture of the same type. In our opinion, in patients on bisphosphonate therapy who present with a spontaneous femur fracture, seizing therapy is advisable. In bilateral cases preventive nailing should be considered.